Mathieu Marx1,2, Isabelle Mosnier3, Frederic Venail4, Michel Mondain4, Alain Uziel4, David Bakhos5, Emmanuel Lescanne5, Yann N'Guyen3, Daniele Bernardeschi3, Olivier Sterkers3, Olivier Deguine1,2, Benoît Lepage6, Benoit Godey7, Sébastien Schmerber8, Nicolas-Xavier Bonne9, Christophe Vincent10, Bernard Fraysse1. 1. Service d'Otologie, Otoneurologie et ORL pédiatrique, Hôpital Pierre-Paul Riquet, CHU Purpan, Toulouse, France. 2. Brain & Cognition Research Centre, UMR 5549, Université Toulouse III, Toulouse, France. 3. AP-HP6, GHU Pitié-Salpêtrière, Service ORL, Unité Fonctionnelle Implants Auditifs et explorations fonctionnelles, Paris, France. 4. Service d'ORL, Hôpital Gui de Chauliac, CHU, Montpellier, France. 5. Service d'ORL, Hôpital Bretonneau, CHU Tours, Tours, France. 6. Unité de Soutien Méthodologique à la Recherche, Faculté de Médecine, Université de Toulouse, Toulouse, France. 7. Service d'ORL, Hôpital Pontchaillou, CHU, Rennes, France. 8. Service d'ORL, CHU, Grenoble, France. 9. Université Lille, Inserm, CHU Lille, Service d'ORL, U1192 - PRISM, Lille, France. 10. Service d'ORL, Hôpital Salengro, CHU, Lille, France.
Abstract
INTRODUCTION: Cochlear implantation is a recent approach proposed to treat single-sided deafness (SSD) and asymmetric hearing loss (AHL). Several cohort studies showed its effectiveness on tinnitus and variable results on binaural hearing. The main objective of this study is to assess the outcomes of cochlear implantation and other treatment options in SSD/AHL on quality of life. METHODS: This prospective multicenter study was conducted in 7 tertiary university hospitals and included an observational cohort study of SSD/AHL adult patients treated using contralateral routing of the signal (CROS) hearing aids or bone-anchored hearing systems (BAHSs) or who declined all treatments, and a randomized controlled trial in subjects treated by cochlear implantation, after failure of CROS and BAHS trials. In total, 155 subjects with SSD or AHL, with or without associated tinnitus, were enrolled. After 2 consecutive trials with CROS hearing aids and BAHSs on headband, all subjects chose any of the 4 treatment options (abstention, CROS, BAHS, or cochlear implant [CI]). The subjects who opted for a CI were randomized between 2 arms (CI vs. initial observation). Six months after the treatment choice, quality of life was assessed using both generic (EuroQoL-5D, EQ-5D) and auditory-specific quality-of-life indices (Nijmegen Cochlear implant Questionnaire [NCIQ] and Visual Analogue Scale [VAS] for tinnitus severity). Performances for speech-in-noise recognition and localization were measured as secondary outcomes. RESULTS: CROS was chosen by 75 subjects, while 51 opted for cochlear implantation, 18 for BAHSs, and 11 for abstention. Six months after treatment, both EQ-5D VAS and auditory-specific quality-of-life indices were significantly better in the "CI" arm versus "observation" arm. The mean effect of the CI was particularly significant in subjects with associated severe tinnitus (mean improvement of 20.7 points ± 19.7 on EQ-5D VAS, 20.4 ± 12.4 on NCIQ, and 51.4 ± 35.4 on tinnitus). No significant effect of the CI was found on binaural hearing results. Before/after comparisons showed that the CROS and BAHS also improved significantly NCIQ scores (for CROS: +7.7, 95% confidence interval [95% CI] = [4.5; 10.8]; for the BAHS: +14.3, 95% CI = [7.9; 20.7]). CONCLUSION: Cochlear implantation leads to significant improvements in quality of life in SSD and AHL patients, particularly in subjects with associated severe tinnitus, who are thereby the best candidates to an extension of CI indications. The Author(s). Published by S. Karger AG, Basel.
INTRODUCTION: Cochlear implantation is a recent approach proposed to treat single-sided deafness (SSD) and asymmetric hearing loss (AHL). Several cohort studies showed its effectiveness on tinnitus and variable results on binaural hearing. The main objective of this study is to assess the outcomes of cochlear implantation and other treatment options in SSD/AHL on quality of life. METHODS: This prospective multicenter study was conducted in 7 tertiary university hospitals and included an observational cohort study of SSD/AHL adult patients treated using contralateral routing of the signal (CROS) hearing aids or bone-anchored hearing systems (BAHSs) or who declined all treatments, and a randomized controlled trial in subjects treated by cochlear implantation, after failure of CROS and BAHS trials. In total, 155 subjects with SSD or AHL, with or without associated tinnitus, were enrolled. After 2 consecutive trials with CROS hearing aids and BAHSs on headband, all subjects chose any of the 4 treatment options (abstention, CROS, BAHS, or cochlear implant [CI]). The subjects who opted for a CI were randomized between 2 arms (CI vs. initial observation). Six months after the treatment choice, quality of life was assessed using both generic (EuroQoL-5D, EQ-5D) and auditory-specific quality-of-life indices (Nijmegen Cochlear implant Questionnaire [NCIQ] and Visual Analogue Scale [VAS] for tinnitus severity). Performances for speech-in-noise recognition and localization were measured as secondary outcomes. RESULTS: CROS was chosen by 75 subjects, while 51 opted for cochlear implantation, 18 for BAHSs, and 11 for abstention. Six months after treatment, both EQ-5D VAS and auditory-specific quality-of-life indices were significantly better in the "CI" arm versus "observation" arm. The mean effect of the CI was particularly significant in subjects with associated severe tinnitus (mean improvement of 20.7 points ± 19.7 on EQ-5D VAS, 20.4 ± 12.4 on NCIQ, and 51.4 ± 35.4 on tinnitus). No significant effect of the CI was found on binaural hearing results. Before/after comparisons showed that the CROS and BAHS also improved significantly NCIQ scores (for CROS: +7.7, 95% confidence interval [95% CI] = [4.5; 10.8]; for the BAHS: +14.3, 95% CI = [7.9; 20.7]). CONCLUSION: Cochlear implantation leads to significant improvements in quality of life in SSD and AHL patients, particularly in subjects with associated severe tinnitus, who are thereby the best candidates to an extension of CI indications. The Author(s). Published by S. Karger AG, Basel.
Entities:
Keywords:
Asymmetric hearing loss; Bone-anchored hearing system; Cochlear implants; Contralateral routing of the signal hearing Aids; Quality of life
Authors: Christophe Vincent; Susan Arndt; Jill B Firszt; Bernard Fraysse; Pádraig T Kitterick; Blake C Papsin; Ad Snik; Paul Van de Heyning; Olivier Deguine; Mathieu Marx Journal: Audiol Neurootol Date: 2015-05-19 Impact factor: 1.854
Authors: G G J Ramakers; Y E Smulders; A van Zon; V J C Kraaijenga; I Stegeman; G A Van Zanten; W Grolman Journal: Clin Otolaryngol Date: 2016-02-12 Impact factor: 2.597
Authors: Jeroen Pm Peters; Alice van Zon; Adriana L Smit; Gijsbert A van Zanten; G Ardine de Wit; Inge Stegeman; Wilko Grolman Journal: BMC Ear Nose Throat Disord Date: 2015-05-23
Authors: Remo A G J Arts; Erwin L J George; Miranda Janssen; Andreas Griessner; Clemens Zierhofer; Robert J Stokroos Journal: PLoS One Date: 2016-04-25 Impact factor: 3.240
Authors: Samar A Idriss; Pierre Reynard; Mathieu Marx; Albane Mainguy; Charles-Alexandre Joly; Eugen Constant Ionescu; Kelly K S Assouly; Hung Thai-Van Journal: J Clin Med Date: 2022-09-26 Impact factor: 4.964